Both infectivity and TSE-specific amyloid protein (also referred to as protease resistant-or prion protein, PrP) are pathognomonic markers for transmissible spongiform encephalopathies (TSE). This paper presents a new densitometric method for the quantification of TSE-specific amyloid protein and its application to studying the pathogenesis of scrapie in Syrian hamsters after infection with scrapie strain 263K. A first study established a close correlation between infectivity and TSE-specific amyloid protein with a doubling time of 2-2.6 days in the brain and cervical spinal cord for both markers. The ratio of infectivity and TSE-specific amyloid protein was relatively constant at a mean value of about 106 protein molecules per infectious unit during the course of infection. A subsequent study addressed the temporal-spatial spread of infection in the central nervous system by tracing the accumulation of the pathological protein. The pathogenetic process was first detected in the spinal cord between vertebrae T4 and Tg, and then showed an anterograde and retrograde spread with a rate of 0.8-1.0 ram/day. There were also some indications for a possible alternative route of spread of infection from the periphery to the brain, other than via the spinal cord. Involvement of the spleen did not appear essential for the early pathogenesis in hamsters orally infected with the 263K strain of scrapie.
Introduction
Transmissible spongiform encephalopathies (TSE), such as scrapie in sheep, bovine spongiform encephalopathy in cattle and Creutzfeldt-Jakob disease in man, are infectious neurodegenerative diseases whose causative agents have so far eluded identification (for review see : Carp et al., 1989; Gajdusek, 1990; Diringer et al., 1994) .
During the course of a TSE infection, a specific pathological protein derived from a host-encoded precursor accumulates preferentially in the central nervous system (CNS) (Bolton et al., 1982 (Bolton et al., , 1987 McKinley et aI., 1983; Diringer et al., 1983; Oesch et aI., 1985; Barry et al., 1986; Basler et aI., 1986; Meyer eta] ., Bendheim et al., 1988) . This protein constitutes the TSE-specific amyloid protein and can be extracted from affected tissues with a high and predictable yield (Beekes et aI., 1995) for Western-blot detection by immunostaining with various antibodies (for review see . Both infectivity and the pathological protein are regarded as hallmarks for TSE.
The discovery of the TSE-specific amyloid protein [also referred to as protease-resistant protein or prion protein (PrP) (Bolton et aI., 1982; McKinley et aI., 1983) ] immediately gave rise to speculation as to whether the protein constituted a pathological byproduct of TSE infections or a structural component of the infectious agent itself (Bolton et al., 1982; Diringer et al., 1983) . Subsequent studies addressing the relationship between infectivity and the pathological protein produced varying and sometimes conflicting results (McKinley et al., 1983; Czub et al., 1986a Czub et al., , 1988 Gabizon et al., 1987 Gabizon et al., , 1988 Bolton et al., 1991; Jendroska eta[., 1991; Rubenstein et a] ., 1991; Race & Ernst, 1992) .
Precise quantification of both infectivity and the TSEspecific amyloid protein is essential for an appraisal of the correlation between the two pathognomonic markers. However, while infectivity is measured by standardized methods (Kimberlin & Walker, 1977; Prusiner et al., 1980 Prusiner et al., , 1982 , the On: Thu, 13 Dec 2018 04:01:29 quantification procedures for the pathological protein are often only semi-quantitative and differ markedly in their reliability and sensitivity (Czub ef al., 1986a (Czub ef al., , 1988 Prusiner et al., 1990; Bolton et al., 1991 ; Rubenstein et al., 1991; Race & Ernst, 1992) . This makes the results of different studies difficult to compare.
Our paper presents a densitometric method for an absolute quantification of TSE-specific amyloid protein in the Western blot. The method was first applied to study the quantitative relationship between the pathological protein and infectivity during the course of a scrapie infection in the brain and spinal cord of orally infected hamsters (Study I). The results obtained in this study suggested that the accumulation of TSE-specific amyloid protein could be used to trace the spread of infection after oral uptake of agent in the cervical, thoracic and lumbar spinal cord, the brain, and possibly the spleen of our animal model (Study II).
Current understanding of the pathogenesis of TSE is based mainly on detailed infectivity studies performed in parenterally infected rodents (Kimberlin & Walker, 1977 , 1979 , 1982 , 1989 Kimberlin et al., 1983a, b; Clarke & Kimberlin, 1984; Carp ef al., 1994) . Pathogenetic processes following the epidemiologically more relevant oral route of infection (for review see: Diringer ef aI., 1994) have been investigated to a lesser extent (Kimberlin & Walker, 1989) . This paper presents a new approach to study the pathogenesis of scrapie in hamsters after oral infection.
Methods
• Tissue samples and experimental design. Tissue samples were taken from Syrian hamsters infected orally with scrapie strain 263K. Hamsters were infected by feeding each animal 10 mg of homogenized brain tissue from a hamster in the terminal stage of scrapie, as described previously (Diringer et a] ., I994).
Study I. To study the correlation of infectivity and TSE-specific amyloid protein, the brain (about 1 g of tissue) and cervical spinal cord (about 70-100 mg of tissue) were taken from three to five hamsters on the following days post-infection (p.i.) : 77, 86, 91, 95, 100, I05, I09, I14, I19, 123, 127 and I33 . All tissue samples were homogenized in Tris-buffered saline (TBS: 10 mM-Tris-HC1, 133 mM-NaC1, pH 7"4). The homogenates contained 50 mg/ml of brain tissue and 70-I00 mg/ml of spinal cord tissue. For a quantitative comparison of infectivity and TSE-specific amyloid protein, the agent titre was determined directly from the homogenate by bioassay (mean error _+ 0"4 logs) as described by Kimberlin & Walker (1986) using dose-incubation curves (Kimberlin & Walker, 1977; Prusiner eta] ., 1980, I982) . The TSE-specific amyloid protein was extracted from I ml of homogenate following a previously published protocol with an established yield of about 70 % (Beekes et al., I995) . After extraction, the protein was quantitated by immunostaining with polyclonal antiserum (Joh. VIII) in the Western blot. The concentration of pathological protein in the homogenate was calculated from the amount of protein detected in the blotted sample, the extraction yield (70%) and the amount of tissue in the starting homogenate.
Two additional brains from hamsters with terminal scrapie were taken from a different inoculation series. This time, infectivity and TSE-specific amyloid protein in whole brain homogenates were determined by bioassay as described above and by quantitative dot blot analysis, respectively.
Study II. For the pathogenesis study, two or three animals were sacrificed at 43, 61, 79, 89, 94, 100, 105, 110, II6, 120, 125 and 135 days p.i. In addition, two animals with early clinical symptoms of scrapie were sacrificed at 153 and 163 days p.i., and another two in the terminal stage of the disease at 166 and 169 days p.i. Brain, spinal cord and spleen were removed. The spinal cord was dissected into segments corresponding to vertebrae C1-C3, C4-C7, T1-T3, T4-T6, T7-T9, T10-T13 and L1-L3 (20-70 mg of tissue each). Homogenates of the different tissue samples containing 50 mg of brain tissue, 20-70 mg of spinal cord tissue or the equivalent of one spleen (50--100 mg of tissue) per i ml were prepared in TBS. Aliquots of 0"I ml were taken from the spleen homogenates for bioassay and replaced by the same volume of TBS. TSE-specific amyloid protein was extracted from all samples as described for Study I and quantified in the Western blot after staining with MAb 3F4 enhanced by biotin-streptavidin.
Control samples from uninfected hamsters were processed as described for the specimens from infected animals.
• SDS-dIsc PAGE and immunoblot. Dilutions of the final pellets from the extraction of TSE-specific anwloid protein were subjected to Western blotting with subsequent immunostaining as described previously (Beekes et al., 1995) .
For Study I, a polyclonaI antiserum (Joh. VIII; generous gift of U. Oberdieck, Berlin, Germany) was used at a dilution of I:2000, combined with alkaline phosphatase-conjugated anti-rabbit IgG from goat (Dako). For Study II, MAb 3F4 was used at a dilution of 1:20000 combined with a biotin-streptavidin enhancement kit (Dako).
The detection limit for TSE-specific amyloid protein in the Westem blot was determined with a highly purified standard from hamster brains (Beekes et al., i995) . For the polyclonal antiserum, the absolute detection threshold was 1'0-1"5 ng; for MAb 3F4 and biotin-streptavidin enhancement, 0"05--0"1 ng.
• Quantification of TSE-specific amyloid protein in the Western blot. Calibration curves were constructed from dilutions containing 1'5-80 ng (immunostaining with Joh. VIII) or 0"05-2"5 ng (immunostaining with MAb 3F4 and biotin-streptavidin enhancement) of the TSE-specific amyloid protein standard. The staining intensities in the molecular mass range 27-30 kDa (main band of the triplet signal) were recorded with a densitometry programme (CS1 Videodevice and CAM software, Cybertech). These intensities were divided by the intensity of the main band of the 80 ng (2"5 ng) standard sample, which was defined as 100%. The resulting relative intensities were plotted against the amount of TSE-specific amyloid protein contained in the standard sample.
Unknown samples were blotted together with two reference samples containing 80 ng (2"5 ng) of the standard protein. Relative staining intensities were determined as described above and absolute amounts of TSE-specific amyloid protein were obtained from the calibration curve (mean error 4-0'2 logs).
The threshold of detection was 30-50 ng of TSE-specific amyloid protein per g of brain and spinal cord tissue after staining with polyclonal antiserum Joh. VIII (Study I). Using MAb 3F4 and biotin-streptavidin enhancement (Study II), concentrations as low as 3'5 ng per g of tissue could be detected in the different specimens.
The quantification method described above is based on the assumption that the standard and the unknown samples do not differ significantly in the relationship between the amount of protein and the staining intensity of the main band (molecular mass 27-30 kDa) in the Western blot. For our specimens, we verified that the relative composition of the different molecular mass sub-species (27-30 kDa, 23-25 kDa, 92~ 20 kDa) of the TSE-specific amyloid protein, as determined by Western blot analysis, did not differ significantly from that of the standard (data not shown).
• Quantification of the TSE-specific amyloid protein in the dot blot. Brain homogenates were treated with sarcosyl, proteinase K and sample buffer (Beekes et al., 1995) and then applied to a PVDF membrane (Millipore) in a Bio-Dot microfiltration apparatus (Bio-Rad). A dilution series containing 0"05-0"5 ng of the TSE-specific amyloid protein standard was applied as a reference. The membrane was stained using MAb 3F4 with biotin-streptavidin enhancement as described for the Western blot. The resulting dots were measured by densitometry (CS1 Videodevice and CAM software, Cybertech). The intensities of unknown samples were converted into absolute amounts of TSE-specific amyloid protein using the calibration curve constructed from the reference samples (mean error of determination _+30%).
• Calculations Study I. The accumulation rates of infectivity and TSE-specific amyloid protein follow the exponential equation A = A ~" 10 ~'
(I) where A ° is the concentration of infectivity (LD~0/g) or of TSE-specific amyIoid protein (ng/g) at t = 0, A the concentration of infectivity or TSE-specific amyloid protein at t, k the accumulation rate (days ~) and t the period of time after t = 0 (days). The accumulation rates were obtained from the slopes of the graphs in Fig. 1 (a, b) and then converted to doubling times. Study II. Equation I can be used to calculate the ratio of the accumulation rates in two different segments, a and b, of the CNS:
(II) where the values for (logA--logA °) can be obtained from the mean slopes of the accumulation curves in Fig. 4 . Ratios k~/k~,,~in and k~/ke~, where b represents any of the segments examined, were determined according to equation II. Since the accumulation rates kel_Ca and ke~_cv were identical (kcl cJGr~n = kc4-c~/k6.-~n and kc~ ca/kc~_c~ = kc4_ev/ke~_ea; results from Study II), it follows that kc~ cv equals both kc~_c~ and kc4_c:. In Study I, k~i ~ and kel_CV were 0'15 and 0' 12 per day, respectively. This allowed the calculation of the k values for all tissues analysed in Study II by multiplying k~/k~r~i ~ by the factor (0'15/day) or k~/kc~ e~ by the factor (0'12/day). Mean k values were determined from k~/k6..~, n and k6/ke~_c~.
The amount of protein at sacrifice, together with the accumulation rate, allowed the determination of the time before sacrifice when the accumulation of TSE-specific amyloid protein exceeded a particular level, for which we chose a concentration of 10 ng/g. While the absolute detection limit for TSE-specific amyloid protein was 3"5 ng per g of tissue, the amount of the protein in most of the positive samples was at least 10 ng/g. Therefore, this value was used as the criterion for the first appearance of the pathological protein.
By the method described above it was possible to reconstruct the temporal-spatial spread of the accumulation of the TSE-specific amyloid protein in individual animals and to determine the rate of spread.
Results

Correlation of infectivity and TSE-specific amyloid protein
Study I quantitatively examined the accumulation of infectivity and of TSE-specific amyloid protein in the brain and cervical spinal cord at different times after oral infection of hamsters. The accumulation of infectivity in the brain and iiiii iiii i iii i! iii i iiiiiiiiiiiiiiiiiiiiiiiiii iii ii!iiiiiiiiiiiiy cervical spinal cord could be detected starting at 86 days p.i. The TSE-specific amyloid protein was first found at 95 days p.i. in the cervical spinal cord and at 100 days p.i. in the brain. It was detected in both tissues at all times thereafter. None of the animals studied had reached the terminal stage of scrapie, but five showed clinical symptoms at 127 and 133 days p.i. The mean infectivity titre found in the brain and cervical spinal cord of these animals was 10 s~ and 10 s4 LD50 per g of tissue, respectively. The corresponding mean concentrations of TSEspecific amyloid protein were 104a ng/g in the brain and 104.4 ng/g in the cervical spinal cord. Fig. 1 (a, b) shows the accumulation of infectivity and TSEspecific amyloid protein during the course of infection. After its first detection, the accumulation of the TSE-specific amyloid protein paralleled the increase of agent titre in the brain and cervical spinal cord. This was also true for a conspicuous plateau phase between 110 and 115 days p.i. The plateau and the associated parallel displacement of the curves possibly resulted from fortuitous selection of animals with a relatively slow progression of infection. However, the data from four independent determinations show a close quantitative correlation between the accumulation of infectivity and TSEspecific amyloid protein.
Considering the plateau phase and the parallel displacement of the curves as multicausal artifacts which should not affect the calculation of accumulation constants, the mean doubling time for both infection markers (from Fig. 1 a, b) was about 2 days in the brain and 2"6 days in the cervical spinal cord. In both tissues the ratio of infectivity and TSE-specific amyloid was found to be relatively constant at a mean value of 104~ LDs0 per ng of the protein (SEM _ 0"I logs; determination from 31 animals). The observed ratio corresponds to approximately 106 protein molecules per unit of infectivity.
For determination of the ratio of infectivity and TSEspecific amyloid protein at the terminal stage of scrapie, the pathological protein was quantified directly from the brain homogenates of two terminally ill hamsters from a different inoculation series. By dot blot analysis, the concentration of TSE-specific amyloid protein was determined as 100 gg per g of brain tissue. Infectivity was found to be 2 x 109 LDs0/g. The ratio of 1"4 x 108 molecules of TSE-specific amyloid protein per infectious unit found for the terminal disease stage corresponds well to the pre-terminal ratio shown above.
The consistency of the relationship between infectivity and pathological protein allowed us to use the accumulation of TSE-specific amyloid protein as a quantitative marker for the spread of infection.
Spread of TSE-specific amyloid protein accumulation in the CNS
In Study II, the accumulation of TSE-specific amyloid protein was measured in the spleen, in different segments of the spinal cord, and in the brain of hamsters after oral ingestion of scrapie agent. Western blots illustrating the sequential appearance and accumulation of TSE-spedfic amyloid protein in the CNS are shown in Fig. 2 (a-d) . Quantitative evaluation of the blots from Study II revealed the tempora[--spatial accumulation profiles presented in Fig. 3 . However, the relationship between the time post-infection (p.i.) and the accumulation of pathological protein was variable: some hamsters sacrificed at the same time p.i. showed markedly different accumulation levels. We therefore ranked the animals not by the time p.i. but according to the accumulation of TSE-specific amyloid protein in the CNS. In Fig. 4 , the amount of pathological protein in the different spinal cord segments and in the brain was plotted against the corresponding total amount of the protein in the CNS. This plot provides an integrated presentation of the study results and reflects the sequential appearance of TSEspecific amyloid protein in different parts of the CNS. It also shows that the contributions of the different spinal cord segments and the brain to the total amount of TSE-specific amyloid protein in the CNS each develop fairly constantly. Clinical symptoms coincided with a critical level of accumulation of the pathological protein.
Until 89 days p.i. we were unable to detect the TSE-specific amyloid protein in the brain or anywhere in the spinal cord. In animals sacrificed at more than 89 days p.i. the following pathogenetic pattern was found. The pathogenetic process first appeared in the thoracic spinal cord between vertebrae T4 and T9. Subsequently, it showed an anLerograde spread via segment TI to T3 towards the cervical spinal cord, The onset of the accumulation of TSE-specific amyIoid protein was detected simultaneously in the cervical spinal cord (CI-C3, ,93( C4-C9) and in the brain. The next segment to show the pathological protein was TI0~I3, finally followed by segment L1-L3.
Analysing 1/20th of the homogenate of entire hamster brains, i.e. 50 mg of homogenized brain tissue, the accumulation of TSE-specific amyloid protein in the brain was first detected when the total amount of the protein in the CNS was about 40 ng. However, an extrapolation of the accumulation curve for the brain in Fig. 4 (dashed line) suggests that the onset of the pathogenetic process in the brain probably could have been detected simultaneously with the onset in T4-T9 if the entire brain had been analysed instead of only 50 mg of tissue. This indicates the possibility of a route of spread of infection which may bypass the spinal cord.
Characteristic spatial profiles were found in the early stages of the accumulation process, when the highest concentrations of TSE-specific amyloid protein occurred in the T4-T9 region of the spinal cord (Fig. 3) . Later on, higher accumulation rates in the other regions of the CNS led to similar concentrations in the brain and all spinal cord segments between CI and TI3. The lumbar spinal cord was remarkable in that a consistent accumulation started relatively late, and then progressed very slowly.
The variation between the incubation period and the accumulation of TSE-specific amyloid protein did not allow a direct determination of absolute accumulation rates, as in Study I. However, the indirect calculation described in Methods showed that the mean accumulation rates in the different segments of the CNS were within a comparable order of magnitude of each other. The individual rates were 0"I4 (brain), 0"I2 (C1-C3, C4-C7 and TI0-TI3), 0"10 (T1-T3), 0"09 (T4-T6 and T7-T9) and 0-05 (L1-L3) per day.
These rates enabled us to use the blotting results for individual animals to determine in retrospect when the reference concentration for the first detectable appearance of the pathological protein, i.e. 10 ng of TSE-specific amyloid protein per g of tissue, was exceeded in different segments of the CNS. This occurred first in spinal cord segment T4-T6, 3 days later in T7-T9, then in T1-T3 (9 days), then in the cervical spinal cord (C1-C3, C4-C7) and in the brain (14 days), then in T10-T13 (16 days), and, finally, in the lumbar segment L1-L3 (31 days; see Table 1 ).
These time intervals can be correlated to the mean distances between the different segments of the CNS to give the rate of spread of TSE-specific amyloid protein accumulation. Starting in segment T4-T6, accumulation progressed to segment C4-C7 in an anterograde direction at a rate of 0"8-0"9 ram/day (Table l a). The higher value of 1"3-1-6 mm/day found for segments anterior to C4-C7 suggests either an actual increase in the rate of spread, or, possibly, an additional retrograde spread originating from the brain. The high apparent rate of spread from segment T4-T6 towards T7-T9 implies that accumulation in segment T7-T9 was not initiated by spread from T4-T6, but by independent invasion from the periphery. Therefore, the spreading rate towards segments T10-T13 and L1-L3 should be calculated starting at T7-T9 (Table 1 b) . Taking all these results together, the overall rate of anterograde and retrograde spread of TSE-specific protein accumulation in the spinal cord was 0"8-1"0 mm/day.
Accumulation of TSE-specific amyloid protein and infectivity in the spleen
TSE-specific amyloid protein was found in the spleens of only three animals. One of these animals (I35 days p.i.) was clinically normal; another (163 days p.i.) showed early clinicaI signs of scrapie, and the third (169 days p.i.) was in the terminal stage. The spleen from the terminally ill animal contained 2"5 ng of the TSE-specific amyloid protein, the spleens of the two others about 0"4 ng each.
Up to 120 days p.i., infectivity was found in the spleen of only three hamsters at 94, 110 and 116 days p.i. The spleens of these animals contained about 102 LD50 each. After 120 days p.i., the spleen always showed accumulation of infectivity. Agent titres varied between 10 ~ and 4 x 10 ~ LDs0 per spleen in animals negative for TSE-specific amyloid protein. The amount of infectious agent in the spleens which also showed accumulation of the pathological protein was about 103 LDs0 (135 days p.i., 163 days p.i.) and 3 x 103 LDs0 (169 days p.i.), respectively.
These findings indicate an approximately tenfold lower ratio between TSE-specific amyloid protein and infectivity in the spleen than in the CNS. However, the small number of animals with both detectable infectivity and pathological protein cannot provide conclusive evidence for a significant discrepancy. In any case, it appears that the spleen does not play a decisive role in the pathogenetic processes preceding neuroinvasion in hamsters orally infected with scrapie strain 263K.
Discussion
The experimental data reported in this paper demonstrate a very close relationship between infectivity and TSE-specific amyloid protein in the brain and cervical spinal cord of hamsters after oral uptake of scrapie agent. In our animal model the accumulation of the protein almost parallels that of infectivity, resulting in a relatively constant ratio of about 10 G molecules of TSE-specific amyloid protein per infectious unit during the course of infection. Previous studies indicating an independent accumulation of TSE-specific amyloid protein and infectivity (Czub eta]., 1986a (Czub eta]., , b, 1988 ) must be revised upon the development of more sensitive analytical methods.
At first glance, the close relationship between infectivity and TSE-specific amyloid protein might be interpreted in favour of the prion- (Prusiner, 1982 (Prusiner, , 1987 (Prusiner, , 1991 or 'modified host protein' hypotheses (Bolton & Bendheim, 1988) which postulate the pathological protein as the infectious agent.
Under closer scrutiny, however, the observed correlation can readily be understood in the context of conventional microbiology without having to postulate a novel class of pathogens. One possibility is that the host-encoded TSEspecific amyloid protein might play a role in the physical protection or trafficking of either a complete virus (Rohwer, 1991; Manuelidis et aI., 1988; Diringer et al., 1994) or a noncoding, TSE-specific nucleic acid (Dickinson & Outram, 1988) . In this case, a putative nucleic acid may well be hidden by the great excess of highly aggregated TSE-specific amyloid protein and could also elude detection for several additional reasons (Somerville, 1994) .
While the quantitative association of infectivity and TSEspecific amyloid protein established in Study I did not shed light on the nature of the TSE agent, it enabled us to study the spread of infection in the CNS of hamsters by tracing the accumulation of the pathological protein.
This pathogenetic approach revealed that, after an oral challenge, the infection enters the spinal cord from the periphery between vertebrae T4 and T9. From this point of entry the rate of spread in the cranial and lumbar direction is 0"8-1"0 mm/day.
These findings are entirely consistent with the observations made in earlier studies on the spread of scrapie infectivity after intraperitoneal or intragastric infection of small rodents (Kimberlin & Walker, 1979 , 1982 , 1989 . Using the TSE-specific amyloid protein as an alternative marker for infection, the concept of TSE pathogenesis introduced by these authors is strongly supported and shown to be extendable to scrapie in orally infected hamsters.
The studies presented in this paper provide no conclusive evidence for the existence of an alternative pathway to the brain other than via the spinal cord. However, some animals with TSE-specific amyloid protein in the brain showed higher concentrations of the pathological protein in C1-C3 than in C4--C7. This would be difficult to explain if the pathogenetic process originated entirely from the lower spinal cord. The apparently higher spreading rate of the pathogenetic process in the cervical spinal cord and the extrapolation of the accumulation curve of the brain in Fig. 4 also imply that the infection may reach the brain not only by ascension from the thoracic spinal cord. An alternative pathway from the periphery to the brain, for example via the vagus nerve, was already suggested by earlier studies (Kimberlin & Walker, 1982) and would be compatible with more recent immunohistochemical findings (Muramoto et al., 1993; van Keulen et aI., 1995) . Follow-up studies to investigate this possibility more closely are in progress.
